← FDA DRUG APPROVALS

FDA ANDA · ANDA062850

CEPHRADINE

Sponsor: BARR

APPLICATION
ANDA062850
TYPE
ANDA
ORIGINAL APPROVAL
1988-04-22
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CEPHRADINEDiscontinued
CEPHRADINE 250MG · CAPSULE · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 12AP
1994-12-23Manufacturing (CMC) · Supplement 11AP
1992-04-03Manufacturing (CMC) · Supplement 10AP
1992-04-03Manufacturing (CMC) · Supplement 8AP
1988-04-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →